688520.SH
神州细胞
SSE · Healthcare · Biotechnology · CN
CNY 36.39
−3.96%Aug 28, 2026, 09:17 UTC
SinoCell Technologies reported a net loss of 366 million yuan for the first half of 2026, compared with a loss of 33.77 million yuan in the same period of 2025.
Source:Aug 19, 2026, 09:10 UTC
Sinocelltech's controlled subsidiary Sinocelltech Engineering received approval from China's National Medical Products Administration to conduct clinical trials for its SCTB10 injection in hemophilia A.